CORRIGENDUM: Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma

Publisher: John Wiley & Sons Inc

E-ISSN: 1532-6535|91|6|1087-1087

ISSN: 0009-9236

Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.6, 2012-06, pp. : 1087-1087

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content